id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_cmb5a3ntvzalhowblcxqo6o7xy	Claus F Vogelmeier	Systemic steroids in COPD-the beauty and the beast	2014	2	.pdf	application/pdf	1568	144	60	In moderate and severe acute exacerbations oral steroids are advocated based on the findings of several placebo-controlled trials that have been there is evidence that chronic therapy with systemic steroids is one of the risk factors for the high rate of osteoporosis that is observed in COPD [12]. away from the chronic use of systemic steroids in COPD Importantly, discontinuation of chronic systemic steroid therapy did not result in an increase of should be prescribed in a moderate dose (40 mg prednisolone) for 5 days, b) there is no place for systemic steroids in stable phase COPD, c) in patients treated with trial of oral prednisone in outpatients with acute COPD exacerbation. acute exacerbations of chronic obstructive pulmonary disease: a exacerbations of chronic obstructive pulmonary disease: the REDUCE steroid-induced myopathy in chronic obstructive pulmonary disease. Cite this article as: Vogelmeier: Systemic steroids in COPD-the beauty	./cache/work_cmb5a3ntvzalhowblcxqo6o7xy.pdf	./txt/work_cmb5a3ntvzalhowblcxqo6o7xy.txt